Digital Health Interventions for Gestational Diabetes
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to explore digital health tools to help women with gestational diabetes manage their condition better during pregnancy. Researchers seek to determine if using a website for information, a digital platform (ePlatform) for tracking activity and weight, or regular health coach calls can improve outcomes like weight control and blood sugar levels. Women between 20 and less than 32 weeks pregnant with gestational diabetes who frequently access a smartphone might be a good fit for this study. Participants will be divided into groups to test different combinations of these tools. Feedback from participants will help shape a larger future study. As an unphased trial, this study offers participants the opportunity to contribute to innovative research that could enhance gestational diabetes management for future patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on digital health interventions for gestational diabetes, so it's best to discuss your medications with the trial team or your doctor.
What prior data suggests that these digital health interventions are safe for women with gestational diabetes?
Research has shown that digital health tools are safe for people with gestational diabetes (GDM). Studies have found that digital platforms effectively manage blood sugar levels without major safety issues. These tools often provide educational resources and track health data to improve outcomes.
Having a health coach for support also proves beneficial. Research suggests that health coaching aids in weight management and improves overall pregnancy outcomes for those with GDM. Reports of harmful effects from these methods are insignificant, indicating general safety.
Both digital platforms and health coaching have been well-received in past studies, with participants often finding them helpful and easy to use. This suggests these methods are not only safe but also practical for managing GDM.12345Why are researchers excited about this trial?
Researchers are excited about these digital health interventions for gestational diabetes because they offer a more personalized and interactive approach compared to standard care options like dietary changes, exercise, and insulin. The ePlatform and health coach combination allows for real-time data tracking and personalized feedback, which can help expectant mothers better manage their weight gain and activity levels. Additionally, the resource bank provides comprehensive and easily accessible information through videos, podcasts, and articles, making it a versatile tool for patient education and empowerment. These digital tools provide a more supportive and continuous engagement, which could lead to better health outcomes for both mothers and their babies.
What evidence suggests that this trial's interventions could be effective for gestational diabetes?
This trial will evaluate various digital health interventions for gestational diabetes. Research has shown that digital health tools, such as online platforms, can help women with gestational diabetes manage their blood sugar more effectively. In this trial, some participants will access a resource bank and ePlatform, which includes tools for tracking weight and physical activity. Others will receive additional support from a health coach, who will provide guidance on exercise and healthy eating. Studies indicate that these tools can lead to healthier pregnancies and better control of blood sugar levels, which is essential for managing gestational diabetes. Together, these approaches aim to maintain healthy weight gain and improve overall health during pregnancy.12467
Who Is on the Research Team?
Kaberi Dasgupta, MD, MSC
Principal Investigator
McGill University Health Centre/Research Institute of the McGill University Health Centre
Are You a Good Fit for This Trial?
This trial is for women with gestational diabetes, between 20 and less than 32 weeks pregnant, followed by a specific doctor group, who speak English or French and have regular access to a modern smartphone. It excludes those with other types of diabetes, multiple pregnancies, non-hospital birth plans, smokers, or conditions that limit exercise during pregnancy.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive access to a website resource bank and are randomized to different intervention groups including ePlatform and health coaching.
Follow-up
Participants are monitored for outcomes such as gestational weight gain, physical activity, and health coaching effectiveness.
Postpartum Evaluation
Completion of postpartum screen for diabetes and assessment of breastfeeding practices.
What Are the Treatments Tested in This Trial?
Interventions
- ePlatform
- Health coach
- Resource bank
Find a Clinic Near You
Who Is Running the Clinical Trial?
McGill University Health Centre/Research Institute of the McGill University Health Centre
Lead Sponsor
The Lawson Foundation
Collaborator